Evidence map›Paper›PMID 41210938›Full record

ArticleFrontiers in cellular and infection microbiology2025

Thymoquinone/β-

Adel Attia M Ahmad, El-Sayed Y El-Naenaeey, Abeer S Aloufi, Eman K Khalifa, Tarek Khamis, Gamal A Elmowalid, Marwa I Abd El-Hamid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adel Attia M AhmadDepartment of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
El-Sayed Y El-NaenaeeyDepartment of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Abeer S AloufiDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Eman K KhalifaDepartment of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Tarek KhamisDepartment of Pharmacology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Gamal A ElmowalidDepartment of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Marwa I Abd El-HamidDepartment of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Disrupting Methods: Results: Treatment with NAGase (2.5 U/mL) and TQ [1× minimum inhibitory concentration (MIC)] significantly reduced existing biofilms in multidrug-resistant and strong biofilm-forming Conclusions: The combination of TQ and NAGase is a promising antibiofilm agent in

Indexed as

AcetylglucosaminidaseAnti-Bacterial AgentsBenzoquinonesBiofilmsQuorum SensingSignal TransductionStaphylococcus aureusBacterial ProteinsGene Expression Regulation, BacterialMicrobial Sensitivity TestsNigella sativaAcetylglucosaminidaseAnti-Bacterial AgentsBacterial ProteinsBenzoquinonesthymoquinonebiofilmquorum sensingStaphylococcus aureusthymoquinoneβ-N-acetylglucosaminidase

Identifiers

PMID41210938
PMCPMC12589069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.